<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00838045</url>
  </required_header>
  <id_info>
    <org_study_id>451</org_study_id>
    <nct_id>NCT00838045</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety &amp; Effectiveness of the Bausch &amp; Lomb AKREOS® TL Intraocular Lens</brief_title>
  <official_title>A Prospective, Multi-Center Clinical Investigation to Evaluate the Safety &amp; Effectiveness of the Bausch &amp; Lomb AKREOS® TL (Model MI60) Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the safety and effectiveness of the Bausch &amp; Lomb Akreos TL (thin&#xD;
      lens) intraocular lens (IOL) following implantation in adults requiring cataract surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bast Corrected Visual Acuity</measure>
    <time_frame>24 months</time_frame>
    <description>best-corrected visual acuity (BCVA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uncorrected Visual Acuity</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manifest Refraction</measure>
    <time_frame>24 Months</time_frame>
    <description>mean manifest refraction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Cataract</condition>
  <condition>Aphakia</condition>
  <arm_group>
    <arm_group_label>Akreos TL intraocular lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb Akreos TL intraocular lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The Bausch &amp; Lomb Akreos TL IOL (MI60) posterior chamber IOL</intervention_name>
    <description>Surgery to implant the Bausch &amp; Lomb Akreos TL Intraocular Lens will be performed using standard microsurgical techniques following cataract surgery.</description>
    <arm_group_label>Akreos TL intraocular lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must have a clinically documented diagnosis of age-related cataract that is&#xD;
             considered amenable to treatment with standard phacoemulsification/extracapsular&#xD;
             cataract extraction.&#xD;
&#xD;
          -  Subjects must be undergoing primary intraocular lens implantation for the correction&#xD;
             of aphakia following continuous curvilinear anterior capsulotomy and&#xD;
             phacoemulsification cataract extraction.&#xD;
&#xD;
          -  Subjects must require a lens power from 15 to 30 diopters.&#xD;
&#xD;
          -  Subjects must have a visual potential of 20/40 or better in the study eye.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with any anterior segment pathology for which extracapsular&#xD;
             phacoemulsification cataract surgery would be contraindicated.&#xD;
&#xD;
          -  Subjects with any inflammation or edema (swelling) of the cornea.&#xD;
&#xD;
          -  Subjects with uncontrolled glaucoma or glaucoma under current treatment in the study&#xD;
             eye or with ocular hypertension.&#xD;
&#xD;
          -  Subjects with previous retinal detachment.&#xD;
&#xD;
          -  Subjects with diabetic retinopathy (proliferative or non-proliferative).&#xD;
&#xD;
          -  Subjects with rubella, bilateral congenital, traumatic, or complicated cataract.&#xD;
&#xD;
          -  Subjects who have had previous ocular surgery in the planned operative eye, excluding&#xD;
             ocular adnexa surgery.&#xD;
&#xD;
          -  Subjects who have already received an Akreos TL IOL in the fellow eye.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Kohnen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der J.W. Goethe-Universität</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum der J.W. Goethe-Universität</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>February 5, 2009</study_first_submitted>
  <study_first_submitted_qc>February 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2009</study_first_posted>
  <last_update_submitted>December 7, 2011</last_update_submitted>
  <last_update_submitted_qc>December 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Aphakia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

